These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4818770)

  • 1. Structural changes in the arginine vasopressin molecule that enhance antidiuretic activity and specificity.
    Sawyer WH; Acosta M; Balaspiri L; Judd J; Manning M
    Endocrinology; 1974 Apr; 94(4):1106-15. PubMed ID: 4818770
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural changes in the arginine vasopressin molecule that prolong its antidiuretic action.
    Sawyer WH; Acosta M; Manning M
    Endocrinology; 1974 Jul; 95(1):140-9. PubMed ID: 4835874
    [No Abstract]   [Full Text] [Related]  

  • 3. Solid phase synthesis of (1-deamino,4-valine)-8-D-arginine-vasopressin (DVDAVP), a highly potent and specific antidiuretic agent possessing protracted effects.
    Manning M; Balaspiri L; Acosta M; Sawyer WH
    J Med Chem; 1973 Sep; 16(9):975-8. PubMed ID: 4745513
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the disulfide bridge and the C-terminal tripeptide in the antidiuretic action of vasopressin in man and the rat.
    Cort JH; Schück O; Stríbrná J; Skopková J; Jost K; Mulder JL
    Kidney Int; 1975 Nov; 8(5):292-302. PubMed ID: 1195561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors.
    Butlen D; Guillon G; Rajerison RM; Jard S; Sawyer WH; Manning M
    Mol Pharmacol; 1978 Nov; 14(6):1006-17. PubMed ID: 732809
    [No Abstract]   [Full Text] [Related]  

  • 6. The antidiuretic action of vasopressin in newborn and infant rats.
    HELLER H
    J Physiol; 1951 Sep; 115(1):43 P. PubMed ID: 14898498
    [No Abstract]   [Full Text] [Related]  

  • 7. Antidiuretic agonism and antagonism of some O-alkylated analogues of vasopressin containing 2-O-alkylated tyrosine.
    Melin P; Lundin S; Vilhardt H; Lindeberg G; Larsson LE; Pliska V
    Eur J Pharmacol; 1980 Oct; 67(2-3):173-7. PubMed ID: 7461030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin analog with extraordinarily high antidiuretic potency: a study of conformation and activity.
    Smith CW; Walter R
    Science; 1978 Jan; 199(4326):297-9. PubMed ID: 619455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of mice to (8-arginine)- and (8-lysine)-vasopressins as antidiuretic hormones.
    Stewart AD
    J Endocrinol; 1973 Oct; 59(1):195-6. PubMed ID: 4748523
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the vasopressin antagonist d/CH2/5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin.
    László FA; Csáti S; Baláspiri L
    Acta Endocrinol (Copenh); 1984 May; 106(1):52-5. PubMed ID: 6730854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats.
    Vávra I; Machová A; Krejcí I
    J Pharmacol Exp Ther; 1974 Jan; 188(1):241-7. PubMed ID: 4809272
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of the antidiuretic activity of vasopressin by tissue homogenates.
    DICKER SE; GREENBAUM AL
    J Physiol; 1956 Apr; 132(1):199-212. PubMed ID: 13320384
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the vasopressin antagonist d(CH2)5 Tyr(Et)VAVP on diuresis in rat.
    László FA; Csáti S; Baláspiri L; Manning M
    Acta Med Hung; 1984; 41(1):65-73. PubMed ID: 6739224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Hormonogen' analogues of lysine vasopressin: rat pressor and antidiuretic activities.
    Kyncl J; Rezábek K; Kasafírek E; Pliska V; Rudinger J
    Eur J Pharmacol; 1974 Oct; 28(2):294-301. PubMed ID: 4422166
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasopressin analogs with high and specific antidiuretic activity.
    Zaoral M
    Int J Pept Protein Res; 1985 Jun; 25(6):561-74. PubMed ID: 3897085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of the natriuretic, antidiuretic and oxytocic actions of neurohypophysial hormones and related peptides: delineation of separate mechanisms of action and assessment of molecular requirements.
    Chan WY
    J Pharmacol Exp Ther; 1976 Mar; 196(3):746-57. PubMed ID: 1263121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid phase synthesis and some hormonal activities of 1-deamino-4-L-valine-8-D-homolysine-and 1-deamino-4-L-valine-8-D-homoarginine-vasopressin.
    Lindeberg G; Karlsson SM; Melin P
    Int J Pept Protein Res; 1977; 10(3):240-4. PubMed ID: 914427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-phase synthesis and some pharmacological properties of deamino-4-threonine analogs of the vasopressins and vasotocin and (deamino)arginine-vasotocin.
    Manning M; Coy EJ; Acosta M; Sawyer WH
    J Med Chem; 1973 Jul; 16(7):836-9. PubMed ID: 4542167
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary report on orpidan diuresis under the effect of antidiuretic hormone].
    ESCH I; HEEGER H
    Klin Wochenschr; 1958 Aug; 36(15):738. PubMed ID: 13576755
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison between the influence of arginine-vasopressin and lysine-vasopressin on water and electrolyte excretion in ewes.
    Kühn E
    Arch Int Pharmacodyn Ther; 1967 Aug; 168(2):417-25. PubMed ID: 6049335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.